Risultati della ricerca - Kenneth L. Dretchen

  • Mostra 1 - 5 risultati su 5
Raffina i risultati
  1. 1
    Intranasal epinephrine in dogs: Pharmacokinetic and heart rate effects

    Intranasal epinephrine in dogs: Pharmacokinetic and heart rate effects di Kenneth L. Dretchen, Zack Mesa, Matthew Robben, Desmond Slade, Scott Hill, Claire Croutch, Kyle Kappeler, Michael Mesa

    Pubblicazione 2020-04-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  2. 2
    Rhythmic Aortic Contractions Induced by Electrical Stimulation In Vivo in the Rat.

    Rhythmic Aortic Contractions Induced by Electrical Stimulation In Vivo in the Rat. di Niaz Sahibzada, Allen W Mangel, Jaclyn E Tatge, Kenneth L Dretchen, Michael R Franz, Renu Virmani, Richard A Gillis

    Pubblicazione 2015-01-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Subdiaphragmatic Vagotomy With Pyloroplasty Ameliorates the Obesity Caused by Genetic Deletion of the Melanocortin 4 Receptor in the Mouse

    Subdiaphragmatic Vagotomy With Pyloroplasty Ameliorates the Obesity Caused by Genetic Deletion of the Melanocortin 4 Receptor in the Mouse di Ghazaul Dezfuli, Richard A. Gillis, Jaclyn E. Tatge, Kimbell R. Duncan, Kenneth L. Dretchen, Patrick G. Jackson, Joseph G. Verbalis, Niaz Sahibzada

    Pubblicazione 2018-03-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Intranasal epinephrine effects on epinephrine pharmacokinetics and heart rate in a nasal congestion canine model

    Intranasal epinephrine effects on epinephrine pharmacokinetics and heart rate in a nasal congestion canine model di Richard Tuttle, Luca Popescu, Scott Hill, Amber Slanczka, Jeffrey Jankowski, Katherine Barre, Erika Krueger, Desmond Slade, Claire Croutch, Matthew Robben, Zack Mesa, Michael Mesa, Kenneth L. Dretchen

    Pubblicazione 2020-04-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  5. 5
    A 13.2 mg epinephrine intranasal spray demonstrates comparable pharmacokinetics, pharmacodynamics, and safety to a 0.3 mg epinephrine autoinjector

    A 13.2 mg epinephrine intranasal spray demonstrates comparable pharmacokinetics, pharmacodynamics, and safety to a 0.3 mg epinephrine autoinjector di David A. Dworaczyk, PhD, Allen L. Hunt, MD, Mike Di Spirito, MSc, Mary Lor, BSc, GrDip, Kenneth L. Dretchen, PhD, Michael J. Lamson, PhD, Jonathan Pollock, MSci, Thelma Ward, PhD

    Pubblicazione 2024-05-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: